Skip to main content
. 2023 Mar 29;19:399–427. doi: 10.3762/bjoc.19.31

Table 1.

Results from cytotoxicity assays of combretastatin D-3 (3) and D-4 (4) against cancer cell lines [18].

Compound IC50 μg·mL−1 (molar concentration)a

KB BC-1 NCI-H187 Vero cells

3 >20
(>60 μM)
>20
(>60 μM)
13.0 ± 0.2
(40 μM)
>50
(>150 μM)
4 >20
(>65 μM)
>20
(>65 μM)
>20
(>65 μM)
>50
(>160 μM)
ellipticine 0.2–0.3 (≈0.8 μM)

aApproximated values of molar concentration after conversion.